In the last 12 months, insiders at Crinetics Pharmaceuticals, Inc. ($CRNX) filed 310 transactions with the SEC: 1 open-market purchases totaling $110,300 and 90 sales totaling $47,259,367. Net insider sentiment: net selling.
Crinetics Pharmaceuticals, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Struthers Richard Scott (President & CEO) — 51 transactions totaling $22,344,150
- Pizzuti Dana (Chief Med and Dev Officer) — 57 transactions totaling $9,759,553
- Wilson Marc (CFO) — 32 transactions totaling $8,575,830
- Betz Stephen F. (Chief Scientific Officer) — 42 transactions totaling $6,333,388
- Knight Jeff E. (Chief Operating Officer) — 30 transactions totaling $5,122,148
View all SEC Filings for Crinetics Pharmaceuticals, Inc. (CRNX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 3961 | $37.77 | 112,018.0000 | 94,548,000 | 3.42% | 0.00% |
| March 16, 2026 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 6371 | $37.11 | 141,342.0000 | 94,548,000 | 4.31% | 0.01% |
| March 16, 2026 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 5950 | $37.11 | 115,979.0000 | 94,548,000 | 4.88% | 0.01% |
| March 16, 2026 | Struthers Richard Scott | President & CEO | S | Common Stock | 8785 | $37.77 | 1,382,983.0000 | 94,548,000 | 0.63% | 0.01% |
| March 16, 2026 | Struthers Richard Scott | President & CEO | S | Common Stock | 13196 | $37.11 | 1,391,768.0000 | 94,548,000 | 0.94% | 0.01% |
| March 16, 2026 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 4241 | $37.77 | 137,101.0000 | 94,548,000 | 3.00% | 0.00% |
| March 12, 2026 | Vivaldi Coelho Rogerio | Director | S | Common Stock | 4477 | $36.08 | 16,823.0000 | 94,548,000 | 21.02% | 0.00% |
| March 12, 2026 | Vivaldi Coelho Rogerio | Director | S | Common Stock | 523 | $36.77 | 16,300.0000 | 94,548,000 | 3.11% | 0.00% |
| March 3, 2026 | Schilke Tobin | Chief Financial Officer | S | Common Stock | 6713 | $39.67 | 78,121.0000 | 94,548,000 | 7.91% | 0.01% |
| March 3, 2026 | Okey Stephanie | Director | S | Common Stock | 3000 | $39.67 | 13,300.0000 | 94,548,000 | 18.40% | 0.00% |
| Feb. 23, 2026 | Knight Jeff E. | Chief Operating Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 94,548,000 | 9999.99% | 0.06% |
| Feb. 23, 2026 | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 34000 | $0.00 | 121,929.0000 | 94,548,000 | 38.67% | 0.04% |
| Feb. 23, 2026 | Schilke Tobin | Chief Financial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 94,548,000 | 9999.99% | 0.05% |
| Feb. 23, 2026 | Schilke Tobin | Chief Financial Officer | A | Common Stock | 32000 | $0.00 | 84,834.0000 | 94,548,000 | 60.57% | 0.03% |
| Feb. 23, 2026 | Struthers Richard Scott | President & CEO | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 94,548,000 | 9999.99% | 0.24% |
| Feb. 23, 2026 | Struthers Richard Scott | President & CEO | A | Common Stock | 62000 | $0.00 | 1,404,964.0000 | 94,548,000 | 4.62% | 0.07% |
| Feb. 23, 2026 | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 94,548,000 | 9999.99% | 0.05% |
| Feb. 23, 2026 | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 30000 | $0.00 | 147,713.0000 | 94,548,000 | 25.49% | 0.03% |
| Feb. 23, 2026 | Kalofonos Isabel | Chief Commercial Officer | A | Common Stock | 34000 | $0.00 | 34,834.0000 | 94,548,000 | 4076.74% | 0.04% |
| Feb. 23, 2026 | Kalofonos Isabel | Chief Commercial Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 94,548,000 | 9999.99% | 0.06% |
| Jan. 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | S | Common Stock | 2500 | $55.00 | 834.0000 | 94,548,000 | 74.99% | 0.00% |
| Jan. 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 97,500.0000 | 94,548,000 | 2.50% | 0.00% |
| Jan. 5, 2026 | Kalofonos Isabel | Chief Commercial Officer | M | Common Stock | 2500 | $40.59 | 3,334.0000 | 94,548,000 | 299.76% | 0.00% |
| Dec. 26, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 18000 | $1.91 | 117,713.0000 | 94,548,000 | 18.05% | 0.02% |
| Dec. 26, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18000 | $0.00 | 90,514.0000 | 94,548,000 | 16.59% | 0.02% |
| Dec. 18, 2025 | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 28400 | $0.00 | 259,058.0000 | 94,548,000 | 9.88% | 0.03% |
| Dec. 18, 2025 | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 16342 | $0.00 | 0.0000 | 94,548,000 | 100.00% | 0.02% |
| Dec. 18, 2025 | Struthers Richard Scott | President & CEO | M | Common Stock | 28400 | $15.29 | 1,342,964.0000 | 94,548,000 | 2.16% | 0.03% |
| Dec. 18, 2025 | Struthers Richard Scott | President & CEO | M | Common Stock | 16342 | $9.28 | 1,314,564.0000 | 94,548,000 | 1.26% | 0.02% |
| Dec. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 69,042.0000 | 94,548,000 | 6.75% | 0.01% |
| Dec. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 5000 | $45.02 | 66,837.0000 | 94,548,000 | 6.96% | 0.01% |
| Dec. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 5000 | $16.89 | 71,837.0000 | 94,548,000 | 7.48% | 0.01% |
| Nov. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 5000 | $16.89 | 71,270.0000 | 94,548,000 | 7.54% | 0.01% |
| Nov. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 100 | $43.27 | 66,270.0000 | 94,548,000 | 0.15% | 0.00% |
| Nov. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 74,042.0000 | 94,548,000 | 6.33% | 0.01% |
| Nov. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 4900 | $42.65 | 66,370.0000 | 94,548,000 | 6.88% | 0.01% |
| Oct. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 5000 | $41.81 | 66,270.0000 | 94,548,000 | 7.02% | 0.01% |
| Oct. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 5000 | $16.89 | 71,270.0000 | 94,548,000 | 7.54% | 0.01% |
| Oct. 1, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 79,042.0000 | 94,548,000 | 5.95% | 0.01% |
| Sept. 26, 2025 | Struthers Richard Scott | President & CEO | S | Common Stock | 4000 | $45.00 | 1,298,222.0000 | 92,926,000 | 0.31% | 0.00% |
| Sept. 26, 2025 | Fust Matthew K | Director | M | Common Stock | 10000 | $1.91 | 38,836.0000 | 92,926,000 | 34.68% | 0.01% |
| Sept. 26, 2025 | Fust Matthew K | Director | S | Common Stock | 16000 | $44.75 | 22,836.0000 | 92,926,000 | 41.20% | 0.02% |
| Sept. 26, 2025 | Fust Matthew K | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 2,092.0000 | 92,926,000 | 82.70% | 0.01% |
| Sept. 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 5000 | $16.89 | 101,270.0000 | 92,926,000 | 5.19% | 0.01% |
| Sept. 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 84,042.0000 | 92,926,000 | 5.62% | 0.01% |
| Sept. 2, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 5000 | $32.10 | 96,270.0000 | 92,926,000 | 4.94% | 0.01% |
| Aug. 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 30000 | $16.89 | 96,270.0000 | 92,926,000 | 45.27% | 0.03% |
| Aug. 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 89,042.0000 | 92,926,000 | 25.20% | 0.03% |
| Aug. 22, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 30000 | $30.43 | 66,270.0000 | 92,926,000 | 31.16% | 0.03% |
| Aug. 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 6492 | $29.18 | 66,270.0000 | 92,926,000 | 8.92% | 0.01% |
| June 12, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 16645 | $9.28 | 197,196.0000 | 92,926,000 | 9.22% | 0.02% |
| June 12, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 16645 | $0.00 | 58,198.0000 | 92,926,000 | 22.24% | 0.02% |
| June 12, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 71525 | $0.00 | 108,514.0000 | 92,926,000 | 39.73% | 0.08% |
| June 12, 2025 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 97483 | $32.23 | 99,713.0000 | 92,926,000 | 49.43% | 0.10% |
| June 12, 2025 | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 71525 | $1.91 | 180,551.0000 | 92,926,000 | 65.60% | 0.08% |
| June 11, 2025 | Bedrosian Camille L | Not found | A | Common Stock | 6900 | $0.00 | 16,300.0000 | 92,926,000 | 73.40% | 0.01% |
| June 11, 2025 | Fust Matthew K | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Fust Matthew K | Not found | A | Common Stock | 6900 | $0.00 | 28,836.0000 | 92,926,000 | 31.46% | 0.01% |
| June 11, 2025 | Vivaldi Coelho Rogerio | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Vivaldi Coelho Rogerio | Not found | A | Common Stock | 6900 | $0.00 | 21,300.0000 | 92,926,000 | 47.92% | 0.01% |
| June 11, 2025 | Okey Stephanie | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Okey Stephanie | Not found | A | Common Stock | 6900 | $0.00 | 16,300.0000 | 92,926,000 | 73.40% | 0.01% |
| June 11, 2025 | Deardorf Caren | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Deardorf Caren | Not found | A | Common Stock | 6900 | $0.00 | 16,300.0000 | 92,926,000 | 73.40% | 0.01% |
| June 11, 2025 | WIERENGA WENDALL | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | WIERENGA WENDALL | Not found | A | Common Stock | 6900 | $0.00 | 116,146.0000 | 92,926,000 | 6.32% | 0.01% |
| June 11, 2025 | Nichols Weston | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| June 11, 2025 | Nichols Weston | Not found | A | Common Stock | 6900 | $0.00 | 16,300.0000 | 92,926,000 | 73.40% | 0.01% |
| June 11, 2025 | Bedrosian Camille L | Not found | A | Stock Option (right to buy) | 10350 | $0.00 | 10,350.0000 | 92,926,000 | 9999.99% | 0.01% |
| May 14, 2025 | Struthers Richard Scott | President & CEO | G | Common Stock | 90400 | $0.00 | 1,302,222.0000 | 92,926,000 | 6.49% | 0.10% |
| May 14, 2025 | Struthers Richard Scott | President & CEO | G | Common Stock | 90400 | $0.00 | 1,302,222.0000 | 92,926,000 | 7.46% | 0.10% |
| April 2, 2025 | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 81270 | $0.00 | 0.0000 | 92,926,000 | 100.00% | 0.09% |
| April 2, 2025 | Struthers Richard Scott | President & CEO | M | Common Stock | 81270 | $1.91 | 1,302,222.0000 | 92,926,000 | 6.66% | 0.09% |
| March 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 127 | $34.83 | 72,233.0000 | 92,926,000 | 0.18% | 0.00% |
| March 19, 2025 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 6801 | $34.17 | 87,852.0000 | 92,926,000 | 7.19% | 0.01% |
| March 19, 2025 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 361 | $34.83 | 87,491.0000 | 92,926,000 | 0.41% | 0.00% |
| March 19, 2025 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 5479 | $34.17 | 108,879.0000 | 92,926,000 | 4.79% | 0.01% |
| March 19, 2025 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 291 | $34.83 | 108,588.0000 | 92,926,000 | 0.27% | 0.00% |
| March 19, 2025 | Struthers Richard Scott | President & CEO | S | Common Stock | 875 | $34.83 | 1,220,952.0000 | 92,926,000 | 0.07% | 0.00% |
| March 19, 2025 | Struthers Richard Scott | President & CEO | S | Common Stock | 16463 | $34.17 | 1,221,827.0000 | 92,926,000 | 1.33% | 0.02% |
| March 19, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 2388 | $34.17 | 72,360.0000 | 92,926,000 | 3.19% | 0.00% |
| March 10, 2025 | Schilke Tobin | Chief Financial Officer | A | Common Stock | 52000 | $0.00 | 52,000.0000 | 92,926,000 | 9999.99% | 0.06% |
| March 10, 2025 | Schilke Tobin | Chief Financial Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 92,926,000 | 9999.99% | 0.09% |
| Feb. 20, 2025 | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 43000 | $0.00 | 114,358.0000 | 92,926,000 | 60.26% | 0.05% |
| Feb. 20, 2025 | Struthers Richard Scott | President & CEO | A | Common Stock | 89000 | $0.00 | 1,238,290.0000 | 92,926,000 | 7.74% | 0.10% |
| Feb. 20, 2025 | Struthers Richard Scott | President & CEO | A | Stock Option (Right to Buy) | 313000 | $0.00 | 313,000.0000 | 92,926,000 | 9999.99% | 0.34% |
| Feb. 20, 2025 | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 43000 | $0.00 | 94,653.0000 | 92,926,000 | 83.25% | 0.05% |
| Feb. 20, 2025 | Knight Jeff E. | Chief Operating Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 92,926,000 | 9999.99% | 0.07% |
| Feb. 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | A | Common Stock | 43000 | $0.00 | 74,748.0000 | 92,926,000 | 135.44% | 0.05% |
| Feb. 20, 2025 | Pizzuti Dana | Chief Med and Dev Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 92,926,000 | 9999.99% | 0.07% |
| Feb. 20, 2025 | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 92,926,000 | 9999.99% | 0.07% |
| Feb. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 5000 | $39.07 | 31,748.0000 | 92,926,000 | 13.61% | 0.01% |
| Feb. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 5000 | $16.89 | 36,748.0000 | 92,926,000 | 15.75% | 0.01% |
| Feb. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 5000 | $0.00 | 119,042.0000 | 92,926,000 | 4.03% | 0.01% |
| Nov. 20, 2024 | Wilson Marc | CFO | J | Common Stock | 473 | $14.98 | 111,565.0000 | 68,175,000 | 0.43% | 0.00% |
| Nov. 20, 2024 | Betz Stephen F. | Chief Scientific Officer | J | Common Stock | 451 | $14.98 | 71,358.0000 | 68,175,000 | 0.64% | 0.00% |
| Jan. 10, 2025 | Kalofonos Isabel | Chief Commercial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 92,926,000 | 9999.99% | 0.11% |
| Jan. 7, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 2500 | $19.64 | 31,748.0000 | 92,926,000 | 8.55% | 0.00% |
| Jan. 7, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 18,500.0000 | 92,926,000 | 11.90% | 0.00% |
| Jan. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 15000 | $0.00 | 124,042.0000 | 92,926,000 | 10.79% | 0.02% |
| Jan. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 15000 | $16.89 | 44,248.0000 | 92,926,000 | 51.29% | 0.02% |
| Jan. 3, 2025 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 15000 | $52.09 | 29,248.0000 | 92,926,000 | 33.90% | 0.02% |
| Dec. 16, 2024 | Betz Stephen F. | Chief Scientific Officer | M | Common Stock | 2331 | $1.91 | 71,358.0000 | 68,175,000 | 3.38% | 0.00% |
| Dec. 16, 2024 | Betz Stephen F. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2331 | $0.00 | 180,039.0000 | 68,175,000 | 1.28% | 0.00% |
| Dec. 2, 2024 | Struthers Richard Scott | President & CEO | S | Common Stock | 10000 | $57.57 | 1,149,290.0000 | 68,175,000 | 0.86% | 0.01% |
| Nov. 22, 2024 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 501 | $56.52 | 51,653.0000 | 68,175,000 | 0.96% | 0.00% |
| Oct. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 14375 | $54.63 | 28,507.0000 | 68,175,000 | 33.52% | 0.02% |
| Oct. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 14375 | $16.89 | 42,882.0000 | 68,175,000 | 50.43% | 0.02% |
| Oct. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 14375 | $0.00 | 139,042.0000 | 68,175,000 | 9.37% | 0.02% |
| Sept. 26, 2024 | Wilson Marc | CFO | M | Stock option (Right to Buy) | 25000 | $0.00 | 89,000.0000 | 68,175,000 | 21.93% | 0.04% |
| Sept. 26, 2024 | Wilson Marc | CFO | M | Common Stock | 25000 | $15.29 | 136,092.0000 | 68,175,000 | 22.50% | 0.04% |
| Sept. 26, 2024 | Wilson Marc | CFO | S | Common Stock | 25000 | $51.11 | 111,092.0000 | 68,175,000 | 18.37% | 0.04% |
| Sept. 10, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 1035 | $51.50 | 68,576.0000 | 68,175,000 | 1.49% | 0.00% |
| Aug. 26, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $53.19 | 69,611.0000 | 68,175,000 | 4.13% | 0.00% |
| Aug. 12, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $47.68 | 72,611.0000 | 68,175,000 | 3.97% | 0.00% |
| July 25, 2024 | Wilson Marc | CFO | S | Common Stock | 19056 | $53.88 | 111,092.0000 | 68,175,000 | 14.64% | 0.03% |
| July 25, 2024 | Wilson Marc | CFO | M | Stock option (Right to Buy) | 19056 | $0.00 | 0.0000 | 68,175,000 | 100.00% | 0.03% |
| July 25, 2024 | Wilson Marc | CFO | M | Common Stock | 19056 | $9.28 | 130,148.0000 | 68,175,000 | 17.15% | 0.03% |
| July 25, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $53.43 | 75,611.0000 | 68,175,000 | 3.82% | 0.00% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 5687 | $19.64 | 78,653.0000 | 68,175,000 | 7.79% | 0.01% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 17499 | $23.98 | 70,079.0000 | 68,175,000 | 33.28% | 0.03% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 27000 | $55.00 | 51,653.0000 | 68,175,000 | 34.33% | 0.04% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 2887 | $20.02 | 72,966.0000 | 68,175,000 | 4.12% | 0.00% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 17499 | $0.00 | 112,501.0000 | 68,175,000 | 13.46% | 0.03% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 2887 | $0.00 | 20,213.0000 | 68,175,000 | 12.50% | 0.00% |
| July 15, 2024 | Knight Jeff E. | Chief Operating Officer | M | Stock option (Right to Buy) | 5687 | $0.00 | 85,313.0000 | 68,175,000 | 6.25% | 0.01% |
| July 15, 2024 | Wilson Marc | CFO | M | Common Stock | 25000 | $20.02 | 136,092.0000 | 68,175,000 | 22.50% | 0.04% |
| July 15, 2024 | Wilson Marc | CFO | S | Common Stock | 25000 | $55.00 | 111,092.0000 | 68,175,000 | 18.37% | 0.04% |
| July 15, 2024 | Wilson Marc | CFO | M | Stock option (Right to Buy) | 25000 | $0.00 | 66,000.0000 | 68,175,000 | 27.47% | 0.04% |
| July 10, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $48.55 | 78,611.0000 | 68,175,000 | 3.68% | 0.00% |
| July 5, 2024 | Hassard James | Chief Commercial Officer | M | Common Stock | 15000 | $19.73 | 44,259.0000 | 68,175,000 | 51.27% | 0.02% |
| July 5, 2024 | Hassard James | Chief Commercial Officer | S | Common Stock | 15000 | $44.08 | 29,259.0000 | 68,175,000 | 33.89% | 0.02% |
| July 5, 2024 | Hassard James | Chief Commercial Officer | M | Stock option (Right to Buy) | 15000 | $0.00 | 130,000.0000 | 68,175,000 | 10.34% | 0.02% |
| July 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 14375 | $16.89 | 42,882.0000 | 68,175,000 | 50.43% | 0.02% |
| July 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 14375 | $44.87 | 28,507.0000 | 68,175,000 | 33.52% | 0.02% |
| July 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 14375 | $0.00 | 153,417.0000 | 68,175,000 | 8.57% | 0.02% |
| June 28, 2024 | Wilson Marc | CFO | M | Common Stock | 32129 | $9.28 | 143,221.0000 | 68,175,000 | 28.92% | 0.05% |
| June 28, 2024 | Wilson Marc | CFO | S | Common Stock | 32129 | $43.61 | 111,092.0000 | 68,175,000 | 22.43% | 0.05% |
| June 28, 2024 | Wilson Marc | CFO | M | Stock option (Right to Buy) | 32129 | $0.00 | 19,056.0000 | 68,175,000 | 62.77% | 0.05% |
| June 26, 2024 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 956 | $44.38 | 52,580.0000 | 68,175,000 | 1.79% | 0.00% |
| June 25, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $45.37 | 80,643.0000 | 68,175,000 | 3.59% | 0.00% |
| June 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 9500 | $0.00 | 167,792.0000 | 68,175,000 | 5.36% | 0.01% |
| June 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 9500 | $45.73 | 27,786.0000 | 68,175,000 | 25.48% | 0.01% |
| June 24, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 9500 | $16.89 | 37,286.0000 | 68,175,000 | 34.19% | 0.01% |
| June 21, 2024 | Hassard James | Chief Commercial Officer | M | Common Stock | 15000 | $19.73 | 44,259.0000 | 68,175,000 | 51.27% | 0.02% |
| June 21, 2024 | Hassard James | Chief Commercial Officer | S | Common Stock | 15000 | $44.66 | 29,259.0000 | 68,175,000 | 33.89% | 0.02% |
| June 21, 2024 | Hassard James | Chief Commercial Officer | M | Stock option (Right to Buy) | 15000 | $0.00 | 145,000.0000 | 68,175,000 | 9.38% | 0.02% |
| June 10, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $43.86 | 83,643.0000 | 68,175,000 | 3.46% | 0.00% |
| June 7, 2024 | Deardorf Caren | Not found | A | Common Stock | 3400 | $0.00 | 9,400.0000 | 68,175,000 | 56.67% | 0.00% |
| June 7, 2024 | Deardorf Caren | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Vivaldi Coelho Rogerio | Not found | A | Common Stock | 3400 | $0.00 | 14,400.0000 | 68,175,000 | 30.91% | 0.00% |
| June 7, 2024 | Vivaldi Coelho Rogerio | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Okey Stephanie | Not found | A | Common Stock | 3400 | $0.00 | 9,400.0000 | 68,175,000 | 56.67% | 0.00% |
| June 7, 2024 | Okey Stephanie | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Nichols Weston | Not found | A | Common Stock | 3400 | $0.00 | 9,400.0000 | 68,175,000 | 56.67% | 0.00% |
| June 7, 2024 | Nichols Weston | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Fust Matthew K | Not found | A | Common Stock | 3400 | $0.00 | 21,936.0000 | 68,175,000 | 18.34% | 0.00% |
| June 7, 2024 | Fust Matthew K | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | Bedrosian Camille L | Not found | A | Common Stock | 3400 | $0.00 | 9,400.0000 | 68,175,000 | 56.67% | 0.00% |
| June 7, 2024 | Bedrosian Camille L | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| June 7, 2024 | WIERENGA WENDALL | Not found | A | Common Stock | 3400 | $0.00 | 109,246.0000 | 68,175,000 | 3.21% | 0.00% |
| June 7, 2024 | WIERENGA WENDALL | Not found | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 68,175,000 | 9999.99% | 0.02% |
| May 28, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $47.49 | 86,643.0000 | 68,175,000 | 3.35% | 0.00% |
| May 10, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $49.43 | 89,643.0000 | 68,175,000 | 3.24% | 0.00% |
| May 8, 2024 | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 107448 | $0.00 | 16,342.0000 | 68,175,000 | 86.80% | 0.16% |
| May 8, 2024 | Struthers Richard Scott | President & CEO | M | Common Stock | 107448 | $9.28 | 1,266,738.0000 | 68,175,000 | 9.27% | 0.16% |
| May 8, 2024 | Struthers Richard Scott | President & CEO | S | Common Stock | 107448 | $49.40 | 1,159,290.0000 | 68,175,000 | 8.48% | 0.16% |
| April 18, 2024 | Struthers Richard Scott | President & CEO | G | Common Stock | 350 | $0.00 | 1,159,290.0000 | 68,175,000 | 0.03% | 0.00% |
| April 15, 2024 | Struthers Richard Scott | President & CEO | M | Stock Option (Right to Buy) | 20000 | $0.00 | 81,270.0000 | 68,175,000 | 19.75% | 0.03% |
| April 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 14375 | $44.47 | 27,786.0000 | 68,175,000 | 34.10% | 0.02% |
| April 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock option (Right to Buy) | 14375 | $0.00 | 177,292.0000 | 68,175,000 | 7.50% | 0.02% |
| April 15, 2024 | Struthers Richard Scott | President & CEO | M | Common Stock | 20000 | $1.91 | 1,159,640.0000 | 68,175,000 | 1.75% | 0.03% |
| April 15, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 14375 | $16.89 | 42,161.0000 | 68,175,000 | 51.73% | 0.02% |
| April 4, 2024 | Struthers Richard Scott | President & CEO | S | Common Stock | 40951 | $49.17 | 1,139,640.0000 | 68,175,000 | 3.47% | 0.06% |
| April 4, 2024 | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 40951 | $0.00 | 123,790.0000 | 68,175,000 | 24.86% | 0.06% |
| April 4, 2024 | Struthers Richard Scott | President & CEO | M | Common Stock | 40951 | $9.28 | 1,180,591.0000 | 68,175,000 | 3.59% | 0.06% |
| March 28, 2024 | Okey Stephanie | Director | S | Common Stock | 17500 | $46.38 | 6,000.0000 | 68,175,000 | 74.47% | 0.03% |
| March 28, 2024 | Okey Stephanie | Director | M | Common Stock | 17500 | $18.29 | 23,500.0000 | 68,175,000 | 291.67% | 0.03% |
| March 28, 2024 | Okey Stephanie | Director | M | Stock Option (right to buy) | 17500 | $0.00 | 0.0000 | 68,175,000 | 0.00% | 0.03% |
| March 22, 2024 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 30000 | $44.22 | 54,939.0000 | 68,175,000 | 35.32% | 0.04% |
| March 22, 2024 | Knight Jeff E. | Chief Operating Officer | M | Common Stock | 30000 | $23.98 | 84,939.0000 | 68,175,000 | 54.61% | 0.04% |
| March 22, 2024 | Knight Jeff E. | Chief Operating Officer | S | Common Stock | 2359 | $45.39 | 52,580.0000 | 68,175,000 | 4.29% | 0.00% |
| March 22, 2024 | Knight Jeff E. | Chief Operating Officer | M | Stock Option (right to buy) | 30000 | $0.00 | 130,000.0000 | 68,175,000 | 18.75% | 0.04% |
| March 20, 2024 | Fust Matthew K | Director | S | Common Stock | 12500 | $43.57 | 18,536.0000 | 68,175,000 | 40.28% | 0.02% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 4375 | $16.89 | 32,875.0000 | 68,175,000 | 15.35% | 0.01% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 4375 | $45.89 | 28,500.0000 | 68,175,000 | 13.31% | 0.01% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 10000 | $16.89 | 38,500.0000 | 68,175,000 | 35.09% | 0.01% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 10000 | $43.28 | 28,500.0000 | 68,175,000 | 25.97% | 0.01% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 714 | $43.69 | 27,786.0000 | 68,175,000 | 2.51% | 0.00% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (right to buy) | 4375 | $0.00 | 201,667.0000 | 68,175,000 | 2.12% | 0.01% |
| March 20, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 191,667.0000 | 68,175,000 | 4.96% | 0.01% |
| March 20, 2024 | Fust Matthew K | Director | M | Common Stock | 12500 | $23.24 | 31,036.0000 | 68,175,000 | 67.44% | 0.02% |
| March 20, 2024 | Fust Matthew K | Director | S | Common Stock | 12500 | $43.57 | 18,536.0000 | 68,175,000 | 40.28% | 0.02% |
| March 20, 2024 | Fust Matthew K | Director | M | Common Stock | 12500 | $23.23 | 31,036.0000 | 68,175,000 | 67.44% | 0.02% |
| March 20, 2024 | Fust Matthew K | Director | M | Stock Option (right to buy) | 17500 | $0.00 | 0.0000 | 68,175,000 | 0.00% | 0.03% |
| March 20, 2024 | Fust Matthew K | Director | M | Stock Option (right to buy) | 12500 | $0.00 | 0.0000 | 68,175,000 | 0.00% | 0.02% |
| March 20, 2024 | Fust Matthew K | Director | M | Stock Option (right to buy) | 12500 | $0.00 | 0.0000 | 68,175,000 | 0.00% | 0.02% |
| March 20, 2024 | Fust Matthew K | Director | S | Common Stock | 17500 | $45.50 | 18,536.0000 | 68,175,000 | 48.56% | 0.03% |
| March 20, 2024 | Fust Matthew K | Director | M | Common Stock | 17500 | $18.29 | 36,036.0000 | 68,175,000 | 94.41% | 0.03% |
| March 20, 2024 | Fust Matthew K | Director | S | Common Stock | 17500 | $43.58 | 18,536.0000 | 68,175,000 | 48.56% | 0.03% |
| March 20, 2024 | Fust Matthew K | Director | M | Common Stock | 17500 | $20.23 | 36,036.0000 | 68,175,000 | 94.41% | 0.03% |
| March 20, 2024 | Fust Matthew K | Director | M | Stock Option (right to buy) | 17500 | $0.00 | 0.0000 | 68,175,000 | 0.00% | 0.03% |
| March 19, 2024 | Wilson Marc | CFO | S | Common Stock | 6942 | $42.91 | 110,630.0000 | 68,175,000 | 5.90% | 0.01% |
| March 18, 2024 | Wilson Marc | CFO | F | Common Stock | 3983 | $38.14 | 117,572.0000 | 68,175,000 | 3.28% | 0.01% |
| March 18, 2024 | Betz Stephen F. | Chief Scientific Officer | F | Common Stock | 3655 | $38.14 | 92,643.0000 | 68,175,000 | 3.80% | 0.01% |
| March 18, 2024 | Hassard James | Chief Commercial Officer | F | Common Stock | 1741 | $38.14 | 29,259.0000 | 68,175,000 | 5.62% | 0.00% |
| March 18, 2024 | Knight Jeff E. | Chief Operating Officer | F | Common Stock | 4283 | $38.14 | 54,939.0000 | 68,175,000 | 7.23% | 0.01% |
| March 18, 2024 | Pizzuti Dana | Chief Med and Dev Officer | F | Common Stock | 411 | $38.14 | 28,500.0000 | 68,175,000 | 1.42% | 0.00% |
| March 18, 2024 | Struthers Richard Scott | President & CEO | F | Common Stock | 12687 | $38.14 | 1,139,640.0000 | 68,175,000 | 1.10% | 0.02% |
| March 4, 2024 | Pizzuti Dana | Chief Med and Dev Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 68,175,000 | 9999.99% | 0.13% |
| March 4, 2024 | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 23000 | $0.00 | 59,222.0000 | 68,175,000 | 63.50% | 0.03% |
| March 4, 2024 | Knight Jeff E. | Chief Operating Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 68,175,000 | 9999.99% | 0.13% |
| March 4, 2024 | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 23000 | $0.00 | 96,298.0000 | 68,175,000 | 31.38% | 0.03% |
| March 4, 2024 | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 68,175,000 | 9999.99% | 0.13% |
| March 4, 2024 | Pizzuti Dana | Chief Med and Dev Officer | A | Common Stock | 23000 | $0.00 | 28,911.0000 | 68,175,000 | 389.11% | 0.03% |
| March 4, 2024 | Struthers Richard Scott | President & CEO | A | Stock Option (right to buy) | 240000 | $0.00 | 240,000.0000 | 68,175,000 | 9999.99% | 0.35% |
| March 4, 2024 | Struthers Richard Scott | President & CEO | A | Common Stock | 65000 | $0.00 | 1,152,327.0000 | 68,175,000 | 5.98% | 0.10% |
| March 4, 2024 | Wilson Marc | CFO | A | Stock Option (right to buy) | 95500 | $0.00 | 95,500.0000 | 68,175,000 | 9999.99% | 0.14% |
| March 4, 2024 | Wilson Marc | CFO | A | Common Stock | 25500 | $0.00 | 121,555.0000 | 68,175,000 | 26.55% | 0.04% |
| March 4, 2024 | Hassard James | Chief Commercial Officer | A | Stock Option (right to buy) | 63000 | $0.00 | 63,000.0000 | 68,175,000 | 9999.99% | 0.09% |
| March 4, 2024 | Hassard James | Chief Commercial Officer | A | Common Stock | 17000 | $0.00 | 31,000.0000 | 68,175,000 | 121.43% | 0.02% |
| Feb. 12, 2024 | Struthers Richard Scott | President & CEO | G | Common Stock | 60000 | $0.00 | 1,087,327.0000 | 68,175,000 | 5.23% | 0.09% |
| Feb. 12, 2024 | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Feb. 12, 2024 | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Feb. 12, 2024 | Struthers Richard Scott | President & CEO | G | Common Stock | 20000 | $0.00 | 1,087,327.0000 | 68,175,000 | 1.87% | 0.03% |
| Nov. 20, 2023 | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 931 | $14.98 | 36,222.0000 | 32,344,371,000 | 2.64% | 0.00% |
| May 22, 2023 | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 891 | $14.98 | 35,291.0000 | 0 | 2.59% | 0.00% |
| Jan. 25, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $37.26 | 73,298.0000 | 68,175,000 | 3.93% | 0.00% |
| Jan. 10, 2024 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $37.65 | 76,298.0000 | 68,175,000 | 3.78% | 0.00% |
| Jan. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 14375 | $35.00 | 5,911.0000 | 68,175,000 | 70.86% | 0.02% |
| Jan. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Non-qualified stock option (Right to Buy) | 14375 | $0.00 | 206,042.0000 | 68,175,000 | 6.52% | 0.02% |
| Jan. 2, 2024 | Wilson Marc | CFO | M | Common Stock | 10000 | $9.28 | 106,055.0000 | 68,175,000 | 10.41% | 0.01% |
| Jan. 2, 2024 | Wilson Marc | CFO | S | Common Stock | 10000 | $35.47 | 96,055.0000 | 68,175,000 | 9.43% | 0.01% |
| Jan. 2, 2024 | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 10000 | $0.00 | 51,185.0000 | 68,175,000 | 16.34% | 0.01% |
| Jan. 3, 2024 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 14375 | $16.89 | 20,286.0000 | 68,175,000 | 243.19% | 0.02% |
| Dec. 26, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $35.89 | 79,298.0000 | 32,344,371,000 | 3.65% | 0.00% |
| Dec. 21, 2023 | Pizzuti Dana | Chief Med and Dev Officer | M | Common Stock | 9583 | $16.89 | 15,494.0000 | 32,344,371,000 | 162.12% | 0.00% |
| Dec. 21, 2023 | Pizzuti Dana | Chief Med and Dev Officer | S | Common Stock | 9583 | $34.57 | 5,911.0000 | 32,344,371,000 | 61.85% | 0.00% |
| Dec. 21, 2023 | Pizzuti Dana | Chief Med and Dev Officer | M | Non-qualified stock option (Right to Buy) | 9583 | $0.00 | 220,417.0000 | 32,344,371,000 | 4.17% | 0.00% |
| Dec. 11, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $32.87 | 82,298.0000 | 32,344,371,000 | 3.52% | 0.00% |
| Nov. 27, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3000 | $31.84 | 85,298.0000 | 32,344,371,000 | 3.40% | 0.00% |
| Nov. 9, 2023 | Struthers Richard Scott | President & CEO | M | Common Stock | 50000 | $1.91 | 1,087,327.0000 | 32,344,371,000 | 4.82% | 0.00% |
| Nov. 9, 2023 | Struthers Richard Scott | President & CEO | M | Incentive stock option (Right to Buy) | 50000 | $0.00 | 101,270.0000 | 32,344,371,000 | 33.05% | 0.00% |
| Nov. 2, 2023 | Struthers Richard Scott | President & CEO | M | Common Stock | 918 | $9.28 | 1,038,245.0000 | 32,344,371,000 | 0.09% | 0.00% |
| Nov. 3, 2023 | Struthers Richard Scott | President & CEO | M | Common Stock | 199082 | $9.28 | 1,236,409.0000 | 32,344,371,000 | 19.19% | 0.00% |
| Nov. 3, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 199082 | $30.56 | 1,037,327.0000 | 32,344,371,000 | 16.10% | 0.00% |
| Nov. 3, 2023 | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 199082 | $0.00 | 164,741.0000 | 32,344,371,000 | 54.72% | 0.00% |
| Nov. 2, 2023 | Struthers Richard Scott | President & CEO | M | Non-qualified stock option (Right to Buy) | 918 | $0.00 | 363,823.0000 | 32,344,371,000 | 0.25% | 0.00% |
| Nov. 2, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 918 | $29.95 | 1,037,327.0000 | 32,344,371,000 | 0.09% | 0.00% |
| Nov. 1, 2023 | Wilson Marc | CFO | M | Common Stock | 10000 | $9.28 | 105,601.0000 | 32,344,371,000 | 10.46% | 0.00% |
| Nov. 1, 2023 | Wilson Marc | CFO | S | Common Stock | 10000 | $28.75 | 95,601.0000 | 32,344,371,000 | 9.47% | 0.00% |
| Nov. 1, 2023 | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 10000 | $0.00 | 61,185.0000 | 32,344,371,000 | 14.05% | 0.00% |
| Oct. 17, 2023 | Krasner Alan Seth | Chief Medical Officer | M | Common Stock | 7000 | $12.01 | 50,210.0000 | 32,344,371,000 | 16.20% | 0.00% |
| Oct. 17, 2023 | Krasner Alan Seth | Chief Medical Officer | M | Non-qualified stock option (Right to Buy) | 7000 | $0.00 | 153,473.0000 | 32,344,371,000 | 4.36% | 0.00% |
| Oct. 17, 2023 | Krasner Alan Seth | Chief Medical Officer | S | Common Stock | 7000 | $30.00 | 43,210.0000 | 32,344,371,000 | 13.94% | 0.00% |
| Aug. 14, 2023 | Struthers Richard Scott | President & CEO | M | Incentve stock option (Right to Buy) | 10000 | $0.00 | 151,270.0000 | 0 | 6.20% | 0.00% |
| Aug. 14, 2023 | Struthers Richard Scott | President & CEO | M | Common Stock | 10000 | $1.91 | 1,037,327.0000 | 0 | 0.97% | 0.00% |
| July 12, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 11459 | $20.17 | 1,041,484.0000 | 0 | 1.09% | 0.00% |
| July 11, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 24384 | $20.14 | 1,052,943.0000 | 0 | 2.26% | 0.00% |
| July 13, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 14157 | $20.35 | 1,027,327.0000 | 0 | 1.36% | 0.00% |
| June 16, 2023 | Bedrosian Camille L | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2023 | Wilson Marc | CFO | S | Common Stock | 10922 | $19.96 | 95,158.0000 | 0 | 10.30% | 0.00% |
| June 20, 2023 | Wilson Marc | CFO | M | Common Stock | 20000 | $9.28 | 115,158.0000 | 0 | 21.02% | 0.00% |
| June 20, 2023 | Wilson Marc | CFO | S | Common Stock | 20000 | $19.97 | 95,158.0000 | 0 | 17.37% | 0.00% |
| June 20, 2023 | Wilson Marc | CFO | M | Non-qualified stock option (Right to Buy) | 20000 | $0.00 | 71,185.0000 | 0 | 21.93% | 0.00% |
| June 16, 2023 | Struthers Richard Scott | President & CEO | S | Common Stock | 50000 | $20.81 | 1,077,327.0000 | 0 | 4.44% | 0.00% |
| June 16, 2023 | Vivaldi Coelho Rogerio | Director | A | Common Stock | 6000 | $0.00 | 11,000.0000 | 0 | 120.00% | 0.00% |
| June 16, 2023 | Vivaldi Coelho Rogerio | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Deardorf Caren | Director | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Deardorf Caren | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 6000 | $0.00 | 105,846.0000 | 0 | 6.01% | 0.00% |
| June 16, 2023 | WIERENGA WENDALL | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Okey Stephanie | Director | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Okey Stephanie | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Nichols Weston | Director | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Nichols Weston | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Fust Matthew K | Director | A | Common Stock | 6000 | $0.00 | 18,536.0000 | 0 | 47.86% | 0.00% |
| June 16, 2023 | Fust Matthew K | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Bedrosian Camille L | Director | A | Common Stock | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Vivaldi Coelho Rogerio | Director | P | Common Stock | 5000 | $22.06 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | Pizzuti Dana | Chief Development Officer | F | Common Stock | 4288 | $15.98 | 12,712.0000 | 0 | 25.22% | 0.00% |
| April 5, 2023 | Pizzuti Dana | Chief Development Officer | S | Common Stock | 8212 | $16.15 | 4,500.0000 | 0 | 64.60% | 0.00% |
| March 16, 2023 | Krasner Alan Seth | Chief Medical Officer | F | Common Stock | 1687 | $17.12 | 42,301.0000 | 0 | 3.84% | 0.00% |
| March 16, 2023 | Knight Jeff E. | Chief Operating Officer | F | Common Stock | 587 | $17.12 | 34,400.0000 | 0 | 1.68% | 0.00% |
| March 16, 2023 | Betz Stephen F. | Chief Scientific Officer | F | Common Stock | 1410 | $17.12 | 86,879.0000 | 0 | 1.60% | 0.00% |
| March 16, 2023 | Struthers Richard Scott | President & CEO | F | Common Stock | 4628 | $17.12 | 1,127,327.0000 | 0 | 0.41% | 0.00% |
| March 16, 2023 | Wilson Marc | CFO | F | Common Stock | 1666 | $17.12 | 106,080.0000 | 0 | 1.55% | 0.00% |
| March 1, 2023 | Hassard James | Chief Commercial Officer | A | Stock Option (right to buy) | 65250 | $0.00 | 65,250.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Knight Jeff E. | Chief Operating Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Knight Jeff E. | Chief Operating Officer | A | Common Stock | 29500 | $0.00 | 34,987.0000 | 0 | 537.63% | 0.00% |
| March 1, 2023 | Betz Stephen F. | Chief Scientific Officer | A | Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Betz Stephen F. | Chief Scientific Officer | A | Common Stock | 23600 | $0.00 | 88,289.0000 | 0 | 36.48% | 0.00% |
| March 1, 2023 | Krasner Alan Seth | Chief Medical Officer | A | Common Stock (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Krasner Alan Seth | Chief Medical Officer | A | Common Stock | 19500 | $0.00 | 43,988.0000 | 0 | 79.63% | 0.00% |
| March 1, 2023 | Pizzuti Dana | Chief Development Officer | A | Stock Option (right to buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Pizzuti Dana | Chief Development Officer | A | Common Stock | 4500 | $0.00 | 17,000.0000 | 0 | 36.00% | 0.00% |
| March 1, 2023 | Hassard James | Chief Commercial Officer | A | Common Stock | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Struthers Richard Scott | President & CEO | A | Common Stock (right to buy) | 287700 | $0.00 | 287,700.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Struthers Richard Scott | President & CEO | A | Common Stock | 61650 | $0.00 | 1,131,955.0000 | 0 | 5.76% | 0.00% |
| March 1, 2023 | Wilson Marc | CFO | A | Stock Option (right to buy) | 112850 | $0.00 | 112,850.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Wilson Marc | CFO | A | Common Stock | 24200 | $0.00 | 107,746.0000 | 0 | 28.97% | 0.00% |
| Feb. 1, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $19.59 | 64,689.0000 | 0 | 4.61% | 0.00% |
| Jan. 25, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 8336 | $21.07 | 67,815.0000 | 0 | 10.95% | 0.00% |
| Nov. 20, 2022 | Knight Jeff E. | Chief Operating Officer | J | Common Stock | 537 | $15.16 | 5,487.0000 | 0 | 10.85% | 0.00% |
| Nov. 20, 2022 | Krasner Alan Seth | Chief Medical Officer | J | Common Stock | 712 | $11.02 | 24,488.0000 | 0 | 2.99% | 0.00% |
| May 20, 2022 | Krasner Alan Seth | Chief Medical Officer | J | Common Stock | 1215 | $11.02 | 23,776.0000 | 0 | 5.39% | 0.00% |
| Nov. 20, 2022 | Wilson Marc | CFO | J | Common Stock | 482 | $11.02 | 83,546.0000 | 0 | 0.58% | 0.00% |
| May 20, 2022 | Wilson Marc | CFO | J | Common Stock | 1446 | $11.02 | 83,064.0000 | 0 | 1.77% | 0.00% |
| Jan. 17, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $18.00 | 76,151.0000 | 0 | 3.94% | 0.00% |
| Jan. 3, 2023 | Betz Stephen F. | Chief Scientific Officer | S | Common Stock | 3126 | $18.35 | 79,277.0000 | 0 | 3.79% | 0.00% |